Trinity shares fall after coagulation sale to Stago
This article was originally published in Clinica
Executive Summary
Shares in Irish diagnostics company Trinity Biotech dropped after the company said it expects revenues to decrease 40% following divestment of its ailing blood coagulation business to haematology specialist Stago Group.